Financhill
Buy
65

BMRN Quote, Financials, Valuation and Earnings

Last price:
$58.26
Seasonality move :
-2.05%
Day range:
$57.70 - $58.98
52-week range:
$52.93 - $94.85
Dividend yield:
0%
P/E ratio:
21.65x
P/S ratio:
3.90x
P/B ratio:
1.93x
Volume:
1.5M
Avg. volume:
2.2M
1-year change:
-31.51%
Market cap:
$11.2B
Revenue:
$2.9B
EPS (TTM):
$2.69

BioMarin Pharmaceutical SEC Filings

Company Filed Form Type Description
BMRN
BioMarin Pharmaceutical
04/26/2024 10-Q 10-Q filing on 04/26/2024 View Form
BMRN
BioMarin Pharmaceutical
02/26/2024 10-K 10-K filing on 02/26/2024 View Form
BMRN
BioMarin Pharmaceutical
11/02/2023 10-Q 10-Q filing on 11/02/2023 View Form
BMRN
BioMarin Pharmaceutical
08/02/2023 10-Q 10-Q filing on 08/02/2023 View Form
BMRN
BioMarin Pharmaceutical
04/28/2023 10-Q 10-Q filing on 04/28/2023 View Form
BMRN
BioMarin Pharmaceutical
02/27/2023 10-K 10-K filing on 02/27/2023 View Form
BMRN
BioMarin Pharmaceutical
10/28/2022 10-Q 10-Q filing on 10/28/2022 View Form
BMRN
BioMarin Pharmaceutical
08/04/2022 10-Q 10-Q filing on 08/04/2022 View Form
BMRN
BioMarin Pharmaceutical
04/29/2022 10-Q 10-Q filing on 04/29/2022 View Form
BMRN
BioMarin Pharmaceutical
02/25/2022 10-K 10-K filing on 02/25/2022 View Form
BMRN
BioMarin Pharmaceutical
10/29/2021 10-Q 10-Q filing on 10/29/2021 View Form
BMRN
BioMarin Pharmaceutical
07/30/2021 10-Q 10-Q filing on 07/30/2021 View Form
BMRN
BioMarin Pharmaceutical
04/30/2021 10-Q 10-Q filing on 04/30/2021 View Form
BMRN
BioMarin Pharmaceutical
02/26/2021 10-K 10-K filing on 02/26/2021 View Form
BMRN
BioMarin Pharmaceutical
11/06/2020 10-Q 10-Q filing on 11/06/2020 View Form
BMRN
BioMarin Pharmaceutical
08/05/2020 10-Q 10-Q filing on 08/05/2020 View Form
BMRN
BioMarin Pharmaceutical
05/01/2020 10-Q 10-Q filing on 05/01/2020 View Form
BMRN
BioMarin Pharmaceutical
02/27/2020 10-K 10-K filing on 02/27/2020 View Form
BMRN
BioMarin Pharmaceutical
11/04/2019 10-Q 10-Q filing on 11/04/2019 View Form
BMRN
BioMarin Pharmaceutical
10/29/2019 10-Q 10-Q filing on 10/29/2019 View Form
BMRN
BioMarin Pharmaceutical
08/02/2019 10-Q 10-Q filing on 08/02/2019 View Form
BMRN
BioMarin Pharmaceutical
04/29/2019 10-Q 10-Q filing on 04/29/2019 View Form
BMRN
BioMarin Pharmaceutical
02/28/2019 10-K 10-K filing on 02/28/2019 View Form
BMRN
BioMarin Pharmaceutical
10/26/2018 10-Q 10-Q filing on 10/26/2018 View Form
BMRN
BioMarin Pharmaceutical
08/03/2018 10-Q 10-Q filing on 08/03/2018 View Form
BMRN
BioMarin Pharmaceutical
04/27/2018 10-Q 10-Q filing on 04/27/2018 View Form
BMRN
BioMarin Pharmaceutical
02/26/2018 10-K 10-K filing on 02/26/2018 View Form
BMRN
BioMarin Pharmaceutical
11/13/2017 10-Q 10-Q filing on 11/13/2017 View Form
BMRN
BioMarin Pharmaceutical
10/31/2017 10-Q 10-Q filing on 10/31/2017 View Form
BMRN
BioMarin Pharmaceutical
08/02/2017 10-Q 10-Q filing on 08/02/2017 View Form
BMRN
BioMarin Pharmaceutical
05/04/2017 10-Q 10-Q filing on 05/04/2017 View Form
BMRN
BioMarin Pharmaceutical
02/27/2017 10-K 10-K filing on 02/27/2017 View Form
BMRN
BioMarin Pharmaceutical
11/03/2016 10-Q 10-Q filing on 11/03/2016 View Form
BMRN
BioMarin Pharmaceutical
08/08/2016 10-Q 10-Q filing on 08/08/2016 View Form
BMRN
BioMarin Pharmaceutical
05/02/2016 10-Q 10-Q filing on 05/02/2016 View Form
BMRN
BioMarin Pharmaceutical
02/29/2016 10-K 10-K filing on 02/29/2016 View Form
BMRN
BioMarin Pharmaceutical
11/02/2015 10-Q 10-Q filing on 11/02/2015 View Form
BMRN
BioMarin Pharmaceutical
08/05/2015 10-Q 10-Q filing on 08/05/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Oklo Stock Double?
Will Oklo Stock Double?

Oklo (NYSE: OKLO) is only a year removed from its SPAC‑enabled debut,…

Why a $5 Stock Is Suddenly a Cash Machine
Why a $5 Stock Is Suddenly a Cash Machine

If you stopped tracking Grab Holdings (NASDAQ: GRAB) after its 2021 SPAC…

Is Roku Stock Undervalued Now?
Is Roku Stock Undervalued Now?

At roughly $89 a share, Roku (NASDAQ: ROKU) trades for barely…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Alerts

Buy
55
INKT alert for Jul 15

MiNK Therapeutics [INKT] is down 36.03% over the past day.

Sell
48
NEGG alert for Jul 15

Newegg Commerce [NEGG] is down 26.42% over the past day.

Buy
77
VBTX alert for Jul 15

Veritex Holdings [VBTX] is up 19.56% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock